Urginafect Plus
Urginafect Plus
Modified released film coated tablets
composition
Each tablet contains 50 mg of mirabegron and 5 mg of solifenacin succinate.
Therapeutic indications
Symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence
as may occur in adult patients with overactive bladder (OAB) syndrome.